SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551986-20-000003
Filing Date
2020-01-10
Accepted
2020-01-10 16:28:58
Documents
3
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K a8-kspanote.htm 8-K 41507
2 EXHIBIT 4.1 exhibit41convpromnote.htm EX-4.1 123019
3 EXHIBIT 10.1 exhibit101spa.htm EX-10.1 148791
  Complete submission text file 0001551986-20-000003.txt   314790
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 20521351
SIC: 2834 Pharmaceutical Preparations